Federal award
KBR WYLE SERVICES, LLC
0154
Contract
Obligated and Ceiling
- Obligated (net)
- $6,091,901.85
- Ceiling (potential value, not spending)
- $11,835,372.00
- Current value
- $11,835,372.00
- Gross positive obligations
- $6,378,185.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0154
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 39 · Aug 30, 2010 to Mar 22, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History39
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 22, 2017 | FY2017 | 1B | C | −$265,693.07 | |
| Jun 27, 2016 | FY2016 | 1A | C | −$20,590.08 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 3, 2015 | FY2015 | 36 | C | $64,293.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 1, 2014 | FY2014 | 35 | C | $24,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 28, 2014 | FY2014 | 34 | C | $18,999.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 13, 2014 | FY2014 | 33 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 7, 2014 | FY2014 | 32 | C | $25,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 4, 2013 | FY2014 | 31 | C | $59,289.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 9, 2013 | FY2013 | 30 | C | $87,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 3, 2013 | FY2013 | 29 | C | $35,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 8, 2013 | FY2013 | 28 | C | $24,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 28, 2013 | FY2013 | 27 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 26, 2013 | FY2013 | 26 | C | $24,381.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 1, 2013 | FY2013 | 25 | C | $59,406.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 12, 2012 | FY2013 | 24 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 19, 2012 | FY2012 | 23 | C | $938,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 13, 2012 | FY2012 | 22 | C | $270,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 23, 2012 | FY2012 | 21 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 20, 2012 | FY2012 | 20 | C | $44,588.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 19, 2012 | FY2012 | 19 | C | $24,131.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 7, 2012 | FY2012 | 18 | C | $100,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 15, 2012 | FY2012 | 17 | C | $172,126.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 23, 2012 | FY2012 | 16 | C | $232,436.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 13, 2012 | FY2012 | 15 | C | $24,679.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 9, 2011 | FY2012 | 14 | C | $275,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 23, 2011 | FY2011 | 13 | C | $102,228.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 13, 2011 | FY2011 | 12 | C | $191,994.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 4, 2011 | FY2011 | 11 | C | $116,020.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 7, 2011 | FY2011 | 10 | C | $213,280.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 1, 2011 | FY2011 | 9 | C | $24,450.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 4, 2011 | FY2011 | 8 | C | $127,926.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 24, 2011 | FY2011 | 7 | C | $84,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 4, 2011 | FY2011 | 6 | C | $96,803.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 9, 2011 | FY2011 | 5 | C | $136,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 28, 2010 | FY2011 | 4 | C | $400,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 9, 2010 | FY2011 | 3 | C | $209,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 21, 2010 | FY2010 | 2 | C | $388,680.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 4, 2010 | FY2010 | 1 | C | $1,190,476.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 30, 2010 | FY2010 | 0 | — | $594,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.